{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:20:54Z","timestamp":1785529254299,"version":"3.56.0"},"reference-count":92,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00561352"],"award-info":[{"award-number":["RS-2025-00561352"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Visual field (VF) testing remains a cornerstone in assessing retinal function by measuring how well different parts of the retina detect light. It is essential for early detection, monitoring, and management of many retinal diseases. By mapping retinal sensitivity, VF exams can reveal functional loss before structural changes become visible. This review summarizes how VF testing is applied across key conditions: hydroxychloroquine (HCQ) retinopathy, age-related macular degeneration (AMD), diabetic retinopathy (DR) and macular edema (DME), and inherited disorders including inherited dystrophies such as retinitis pigmentosa (RP). Traditional methods like the Goldmann kinetic perimetry and simple tools such as the Amsler grid help identify large or central VF defects. Automated perimetry (e.g., Humphrey Field Analyzer) provides detailed, quantitative data critical for detecting subtle paracentral scotomas in HCQ retinopathy and central vision loss in AMD. Frequency-doubling technology (FDT) reveals early neural deficits in DR before blood vessel changes appear. Microperimetry offers precise, localized sensitivity maps for macular diseases. Despite its value, VF testing faces challenges including patient fatigue, variability in responses, and interpretation of unreliable results. Recent advances in artificial intelligence, virtual reality perimetry, and home-based perimetry systems are improving test accuracy, accessibility, and patient engagement. Integrating VF exams with these emerging technologies promises more personalized care, earlier intervention, and better long-term outcomes for patients with retinal disease.<\/jats:p>","DOI":"10.3390\/jcm14155266","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T12:56:43Z","timestamp":1753448203000},"page":"5266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Visual Field Examinations for Retinal Diseases: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5125-7170","authenticated-orcid":false,"given":"Ko Eun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Asan Medical Center, Ulsan University College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-8344","authenticated-orcid":false,"given":"Seong Joon","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul 04763, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rai, B.B., Sabeti, F., Carle, C.F., and Maddess, T. (2024). Visual Field Tests: A Narrative Review of Different Perimetric Methods. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092458"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1097\/OPX.0b013e3182004c3b","article-title":"A history of perimetry and visual field testing","volume":"88","author":"Johnson","year":"2011","journal-title":"Optom. Vis. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1444-0938.2005.tb06671.x","article-title":"Recent developments in perimetry: Test stimuli and procedures","volume":"88","author":"McKendrick","year":"2005","journal-title":"Clin. Exp. Optom."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.survophthal.2022.02.004","article-title":"Advanced retinal imaging and applications for clinical practice: A consensus review","volume":"67","author":"Sadda","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.preteyeres.2007.08.001","article-title":"A framework for comparing structural and functional measures of glaucomatous damage","volume":"26","author":"Hood","year":"2007","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101307","DOI":"10.1016\/j.preteyeres.2024.101307","article-title":"Standard automated perimetry for glaucoma and diseases of the retina and visual pathways: Current and future perspectives","volume":"104","author":"Phu","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_7","first-page":"895","article-title":"The accuracy of confrontation visual field test in comparison with automated perimetry","volume":"83","author":"Johnson","year":"1991","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_8","unstructured":"Ruia, S., and Tripathy, K. (2025). Humphrey Visual Field. StatPearls, StatPearls Publishing."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ophtha.2020.10.029","article-title":"Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy","volume":"128","author":"Ahn","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, K.E., Ryu, S.J., Kim, Y.H., Seo, Y., and Ahn, S.J. (2022). Visual field examinations using different strategies in Asian patients taking hydroxychloroquine. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-19048-0"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archopht.1986.01050130075023","article-title":"Asymmetry and variation in the normal hill of vision","volume":"104","author":"Katz","year":"1986","journal-title":"Arch. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1444-0938.2000.tb04907.x","article-title":"Visual fields in glaucoma: A clinical overview","volume":"83","author":"Wood","year":"2000","journal-title":"Clin. Exp. Optom."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archophthalmol.2010.71","article-title":"The effective dynamic ranges of standard automated perimetry sizes III and V and motion and matrix perimetry","volume":"128","author":"Wall","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hepworth, L.R., and Rowe, F.J. (2018). Programme choice for perimetry in neurological conditions (PoPiN): A systematic review of perimetry options and patterns of visual field loss. BMC Ophthalmol., 18.","DOI":"10.1186\/s12886-018-0912-1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1167\/iovs.61.6.56","article-title":"Visual Field Progression in Retinitis Pigmentosa","volume":"61","author":"Xu","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0161-6420(98)96009-2","article-title":"Patterns of visual field progression in patients with retinitis pigmentosa","volume":"105","author":"Grover","year":"1998","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0161-6420(02)01726-8","article-title":"Automated perimetry: A report by the American Academy of Ophthalmology","volume":"109","author":"Delgado","year":"2002","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajo.2024.07.024","article-title":"Comparative Analysis of 24-2C, 24-2, and 10-2 Visual Field Tests for Detecting Mild-Stage Glaucoma With Central Visual field Defects","volume":"268","author":"Nishijima","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ophtha.2021.03.014","article-title":"Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients","volume":"128","author":"Phu","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/IJG.0000000000001844","article-title":"Agreement Between 10-2 and 24-2C Visual Field Test Protocols for Detecting Glaucomatous Central Visual Field Defects","volume":"30","author":"Chakravarti","year":"2021","journal-title":"J. Glaucoma"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1600-0420.1998.760303.x","article-title":"Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma","volume":"76","author":"Bengtsson","year":"1998","journal-title":"Acta Ophthalmol. Scand."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2018.10.010","article-title":"A New SITA Perimetric Threshold Testing Algorithm: Construction and a Multicenter Clinical Study","volume":"198","author":"Heijl","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/archopht.1987.01060110090039","article-title":"Normal variability of static perimetric threshold values across the central visual field","volume":"105","author":"Heijl","year":"1987","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9394(02)01392-2","article-title":"Hydroxychloroquine and chloroquine retinopathy: Screening for drug toxicity","volume":"133","author":"Browning","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"ref_29","first-page":"413","article-title":"Screening for glaucomatous visual field loss with frequency-doubling perimetry","volume":"38","author":"Johnson","year":"1997","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamaophthalmol.2013.5511","article-title":"Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: A prospective study","volume":"132","author":"Liu","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1167\/iovs.19-28063","article-title":"Visual Field Loss in Patients With Diabetes in the Absence of Clinically-Detectable Vascular Retinopathy in a Nationally Representative Survey","volume":"60","author":"Bao","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2004.08.060","article-title":"Microperimetry\u2014Comparison between the micro perimeter 1 and scanning laser ophthalmoscope\u2014Fundus perimetry","volume":"139","author":"Rohrschneider","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/eye.2017.27","article-title":"Structure-function relationship in early diabetic retinopathy: A spatial correlation analysis with OCT and microperimetry","volume":"31","author":"Montesano","year":"2017","journal-title":"Eye"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sjopt.2011.01.010","article-title":"Microperimetry in diabetic retinopathy","volume":"25","author":"Midena","year":"2011","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/IAE.0b013e3181c96986","article-title":"Microperimetry and fundus autofluorescence in diabetic macular edema: Subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation","volume":"30","author":"Vujosevic","year":"2010","journal-title":"Retina"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s40123-022-00568-x","article-title":"Impact of Intravitreal Anti-VEGF Therapy on Microperimetry of the Retinal Nonperfusion Areas of Patients with Proliferative Diabetic Retinopathy","volume":"11","author":"Parravano","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archopht.1993.01090060064024","article-title":"Validity and interpretation of Amsler grid reports","volume":"111","author":"Schuchard","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ophtha.2015.12.003","article-title":"Efficacy of the Amsler Grid Test in Evaluating Glaucomatous Central Visual Field Defects","volume":"123","author":"Su","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bjo.2008.149088","article-title":"The Amsler grid in modern clothes","volume":"93","author":"Frisen","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bjo.2010.194886","article-title":"Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing","volume":"95","author":"Robison","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jamaophthalmol.2022.6396","article-title":"Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis","volume":"141","author":"Bjerager","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-66014-7_1","article-title":"Age-Related Macular Degeneration: Epidemiology and Clinical Aspects","volume":"1256","author":"Keenan","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/s41433-024-03033-0","article-title":"Retinal sensitivity changes in early\/intermediate AMD: A systematic review and meta-analysis of visual field testing under mesopic and scotopic lighting","volume":"38","author":"Trinh","year":"2024","journal-title":"Eye"},{"key":"ref_45","unstructured":"Hobbs, S.D., Tripathy, K., and Pierce, K. (2025). Wet Age-Related Macular Degeneration (AMD). StatPearls, StatPearls Publishing."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: Clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1167\/iovs.61.3.55","article-title":"Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration","volume":"61","author":"Pondorfer","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients","volume":"53","author":"Verbraak","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pinilla, I., Ferreras, A., Idoipe, M., Sanchez-Cano, A.I., Perez-Garcia, D., Herrera, L.X., Pinilla, M.J., and Abecia, E. (2013). Changes in frequency-doubling perimetry in patients with type I diabetes prior to retinopathy. Biomed. Res. Int., 2013.","DOI":"10.1155\/2013\/341269"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2337\/diacare.21.11.2003","article-title":"Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy","volume":"21","author":"Lobefalo","year":"1998","journal-title":"Diabetes Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Hanif","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajo.2007.03.023","article-title":"Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy","volume":"144","author":"Bourla","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0161-6420(99)90342-1","article-title":"Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older","volume":"106","author":"Grover","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ng0997-122b","article-title":"A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy","volume":"17","author":"Allikmets","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0002-9394(99)00236-6","article-title":"A novel mutation in the ABCR gene in four patients with autosomal recessive Stargardt disease","volume":"128","author":"Zhang","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ophtha.2014.08.012","article-title":"Clinical and molecular characteristics of childhood-onset Stargardt disease","volume":"122","author":"Fujinami","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaophthalmol.2017.4152","article-title":"Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)","volume":"135","author":"Strauss","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.10.3.18","article-title":"Correlation of Morphology and Function of Flecks Using Short-Wave Fundus Autofluorescence and Microperimetry in Patients With Stargardt Disease","volume":"10","author":"Dhooge","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bjophthalmol-2018-313278","article-title":"Progressive cone and cone-rod dystrophies: Clinical features, molecular genetics and prospects for therapy","volume":"103","author":"Gill","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40662-023-00349-y","article-title":"Central serous chorioretinopathy: Updates in the pathogenesis, diagnosis and therapeutic strategies","volume":"10","author":"Zhang","year":"2023","journal-title":"Eye Vis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: Towards an evidence-based treatment guideline","volume":"73","author":"Yzer","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: Update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaophthalmol.2013.5515","article-title":"Branch retinal vein occlusion: Natural history of visual outcome","volume":"132","author":"Hayreh","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2010.04.019","article-title":"Natural history of visual outcome in central retinal vein occlusion","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/IAE.0000000000001749","article-title":"Evaluation Of Macular Ischemia In Eyes With Central Retinal Vein Occlusion: An Optical Coherence Tomography Angiography Study","volume":"38","author":"Ghashut","year":"2018","journal-title":"Retina"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archopht.117.6.744","article-title":"Macular hole formation: New data provided by optical coherence tomography","volume":"117","author":"Gaudric","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0161-6420(98)93562-X","article-title":"Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study","volume":"105","author":"Ezra","year":"1998","journal-title":"Ophthalmology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.visres.2006.07.005","article-title":"Macular hole: Perceptual filling-in across central scotomas","volume":"46","author":"Wittich","year":"2006","journal-title":"Vision. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00417-020-04719-3","article-title":"Long-term improvement of retinal sensitivity after macular hole surgery over at least 9-year-old follow-up: A case series","volume":"258","author":"Nicolai","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1167\/iovs.15-16915","article-title":"Progression of Vision Loss in Macular Telangiectasia Type 2","volume":"56","author":"Heeren","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ophtha.2013.12.002","article-title":"Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy","volume":"121","author":"Marmor","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/iovs.63.1.12","article-title":"Visual Field Characteristics in East Asian Patients With Occult Macular Dystrophy (Miyake Disease): EAOMD Report No. 3","volume":"63","author":"Ahn","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/eye.2011.245","article-title":"Humphrey visual field findings in hydroxychloroquine toxicity","volume":"25","author":"Anderson","year":"2011","journal-title":"Eye"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/IAE.0000000000002408","article-title":"Sequential Changes In Hydroxychloroquine Retinopathy Up To 20 Years After Stopping The Drug: Implications for Mild Versus Severe Toxicity","volume":"39","author":"Pham","year":"2019","journal-title":"Retina"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/APO.0000000000000597","article-title":"Microperimetry in Retinal Diseases","volume":"12","author":"Horie","year":"2023","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"Ledsam","year":"2018","journal-title":"Nat. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2017.18152","article-title":"Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes","volume":"318","author":"Ting","year":"2017","journal-title":"JAMA"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Li, F., Wang, Z., Qu, G., Song, D., Yuan, Y., Xu, Y., Gao, K., Luo, G., Xiao, Z., and Lam, D.S.C. (2018). Automatic differentiation of Glaucoma visual field from non-glaucoma visual filed using deep convolutional neural network. BMC Med. Imaging, 18.","DOI":"10.1186\/s12880-018-0273-5"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ophtha.2016.05.029","article-title":"Detecting Preperimetric Glaucoma with Standard Automated Perimetry Using a Deep Learning Classifier","volume":"123","author":"Asaoka","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.8.1.17","article-title":"Portable Perimetry Using Eye-Tracking on a Tablet Computer-A Feasibility Assessment","volume":"8","author":"Jones","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/IJG.0000000000002290","article-title":"Reliability of Visual Field Testing in a Telehealth Setting Using a Head-Mounted Device: A Pilot Study","volume":"33","author":"McLaughlin","year":"2024","journal-title":"J. Glaucoma"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41433-023-02843-y","article-title":"Virtual reality headsets for perimetry testing: A systematic review","volume":"38","author":"Selvan","year":"2024","journal-title":"Eye"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Shin, J.H., Kim, M., Lee, J.Y., Kim, M.Y., Jeon, Y.J., and Kim, K. (2023). Feasibility of hemispatial neglect rehabilitation with virtual reality-based visual exploration therapy among patients with stroke: Randomised controlled trial. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1142663"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.oret.2023.10.012","article-title":"Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility Study","volume":"8","author":"Blinder","year":"2024","journal-title":"Ophthalmol. Retina"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/IAE.0000000000004167","article-title":"Prospective Trial of Home Optical Coherence Tomography-Guided Management of Treatment Experienced Neovascular Age-Related Macular Degeneration Patients","volume":"44","author":"Holekamp","year":"2024","journal-title":"Retina"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Dolar-Szczasny, J., Drab, A., and Rejdak, R. (2024). Home-monitoring\/remote optical coherence tomography in teleophthalmology in patients with eye disorders-a systematic review. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1442758"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:04Z","timestamp":1760033764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":92,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155266"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155266","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}